Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAR
1226
DELISTED
Exar Corporation
EXAR
| $7.13M | 0.02% |
1,162,662
-78,306
| -6% | -$480K |
|
1227
GSK
GSK
$101B
| $7.12M | 0.02% |
141,120
-1,003,360
| -88% | -$51.1M |
|
|
LABL
1228
DELISTED
Multi-Color Corp
LABL
| $7.1M | 0.02% |
118,700
-49,500
| -29% | -$3.4M |
|
1229
Neogen
NEOG
$2.5B
| $7.07M | 0.02% |
333,600
-393,715
| -54% | -$8.03M |
|
1230
Simmons First National
SFNC
$3.45B
| $7.06M | 0.02% |
275,000
+44,000
| +19% | +$1.16M |
|
1231
Civeo
CVEO
$345M
| $7.05M | 0.02% |
413,833
+28,922
| +8% | +$635K |
|
1232
KLA
KLAC
$272B
| $7.02M | 0.02% |
1,012,840
-1,342,000
| -57% | -$8.59M |
|
|
ASCMA
1233
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $7.02M | 0.02% |
419,900
+64,800
| +18% | +$1.39M |
|
1234
United Natural Foods
UNFI
$2.9B
| $7.02M | 0.02% |
178,350
-2,400
| -1% | -$112K |
|
1235
HealthStream
HSTM
$829M
| $7.01M | 0.02% |
318,500
-28,058
| -8% | -$655K |
|
|
GPOR
1236
DELISTED
Gulfport Energy Corp.
GPOR
| $6.99M | 0.02% |
284,600
-19,934
| -7% | -$561K |
|
1237
Camden National
CAC
$990M
| $6.97M | 0.02% |
237,300
+81,450
| +52% | +$2.32M |
|
1238
NGL Energy Partners
NGL
$2.12B
| $6.97M | 0.02% |
631,600
+568,986
| +909% | +$9.16M |
|
1239
SPS Commerce
SPSC
$2.75B
| $6.97M | 0.02% |
198,600
-4,600
| -2% | -$168K |
|
1240
Granite Construction
GVA
$5.52B
| $6.95M | 0.02% |
161,900
+94,700
| +141% | +$3.55M |
|
1241
Sunstone Hotel Investors
SHO
$2.01B
| $6.95M | 0.02% |
556,022
+167,342
| +43% | +$2.37M |
|
|
ELOS
1242
DELISTED
Syneron Medical Ltd
ELOS
| $6.94M | 0.02% |
900,606
-12,174
| -1% | -$92.8K |
|
|
COHR
1243
DELISTED
Coherent Inc
COHR
| $6.94M | 0.02% |
106,591
+4,391
| +4% | +$271K |
|
|
FPO
1244
DELISTED
First Potomac Realty Trust
FPO
| $6.93M | 0.02% |
608,364
+200,864
| +49% | +$2.3M |
|
1245
Eldorado Gold
EGO
$10.4B
| $6.93M | 0.02% |
466,800
+122,280
| +35% | +$2.06M |
|
|
SYNH
1246
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $6.92M | 0.02% |
142,700
+17,600
| +14% | +$783K |
|
1247
Valmont Industries
VMI
$9.52B
| $6.9M | 0.02% |
65,100
+49,900
| +328% | +$5.41M |
|
|
EEP
1248
DELISTED
Enbridge Energy Partners
EEP
| $6.88M | 0.02% |
298,212
+4,512
| +2% | +$113K |
|
|
BPFH
1249
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $6.88M | 0.02% |
606,300
+231,600
| +62% | +$2.69M |
|
|
CBI
1250
DELISTED
Chicago Bridge & Iron Nv
CBI
| $6.86M | 0.01% |
+175,930
| New | +$7.31M |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.